1. COPD Therapeutics in Asia-Pacific Markets to 2022-Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

2. COPD Therapeutics in Asia-Pacific Markets to 2022- Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. COPD occurs most often in older people, but can also affect people in their middle ages. It is a major cause of chronic morbidity and mortality globally. Many people suffer from this disease for years, and die from it or its complications, and it constitutes a substantial economic and social burden. Request a sample of this report @ http://www.orbisresearch.com/contacts/request- sample/183850.http://www.orbisresearch.com/contacts/request- sample/183850 The marketed products landscape comprises a wide range of treatment options, including bronchodilator combinations, bronchodilator and ICS combinations, bronchodilator monotherapies and PDE-4 inhibitors. However, the market is undergoing a gradual transition, away from bronchodilator and ICS therapies and towards targeted and triple combination drug treatments. The market is set to be driven by recently launched products, and the approval of novel drugs that will supplement current market leaders and offer greater therapeutic options. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

3. About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com COPD Therapeutics in Asia-Pacific Markets to 2022- Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies